Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07582848 · ClinicalTrials.gov registry record · NA
BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease
A NA study, sponsored by Carelon Research.
- Not yet
- Registry status
- NA
- Development phase
- 266
- Enrollment target
NCT07582848: Clinical Trial NA study, sponsored by Carelon Research.
NCT07582848 is a NA study that has not yet begun recruiting, run by Carelon Research. The registered enrollment target is 266 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07582848, a NA study, has not yet begun recruiting, sponsored by Carelon Research.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
Study Summary
The primary objective of this study is to enhance the rates of direct breast feeding (DBF) among infants with congenital heart disease (CHD), and to gain insights into the implications of DBF on key metrics of child and parent well-being. A multicenter parallel cluster platform design will be employed. The intervention will be a multifaceted approach to enhance direct breastfeeding. Participating sites will be randomized into either intervention (strategies to enhance direct breastfeeding) or conventional care.
Primary Outcome
any direct breastfeeding (yes/no)
Interventions
- OTHER Breastfeeding clinical practice guideline (CPG) for congenital heart disease (CHD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2026-04 |
| Est. Completion | 2030-06 |
| Phase | NA |
What is known before NCT07582848 opens enrollment
NCT07582848 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which Breastfeeding clinical practice guideline (CPG) for congenital heart disease (CHD) is the first listed.
NCT07582848 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07582848 about?
NCT07582848 is a clinical study titled "BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease". The primary objective of this study is to enhance the rates of direct breast feeding (DBF) among infants with congenital heart disease (CHD), and to gain insights into the implications of DBF on key metrics of child and parent well-being. A multicenter parallel cluster platform design will be employ...
What is the current status of trial NCT07582848?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 266 participants. The study started on 2026-04. Estimated completion is 2030-06.
What interventions are being tested in trial NCT07582848?
The interventions under investigation include: Breastfeeding clinical practice guideline (CPG) for congenital heart disease (CHD) (OTHER).
Who is sponsoring clinical trial NCT07582848?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07582848's enrollment target sits among peer trials
266 395th of 2000 higher than 1,606 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05098652 · 266 participants · NA
Coaching Dementia Caregivers to Master Care-Resistant Behavior
- NCT06088277 · 266 participants · NA
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
- NCT06261814 · 266 participants · Phase 2
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
- NCT06312124 · 266 participants · NA
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia